
Ukraine Targets Outdated Military Equipment in Ongoing Conflict
Section: Politics
U.S. outpatient prescriptions for ivermectin and hydroxychloroquine saw dramatic increases during the COVID-19 pandemic, reaching levels 2 to 10 times higher than those prior to the pandemic, according to recent research from the University of California, Los Angeles (UCLA). Despite substantial evidence indicating their ineffectiveness against the virus, nearly three million prescriptions related to COVID-19 were issued from January 30, 2020, through June 30, 2023, amounting to an estimated expenditure of $272 million.
The study highlighted that usage of these medications was particularly prevalent among older adults aged 65 and above, who were three times more likely to receive prescriptions compared to younger adults aged 18 to 64. Additionally, the data revealed that ivermectin prescriptions were notably higher in socially vulnerable neighborhoods and significantly concentrated in the Southern United States.
Published in the journal Health Affairs, the findings emphasize the need for policy reforms aimed at addressing misinformation surrounding COVID-19 treatments, particularly in marginalized communities. The researchers utilized insurance claims data from the Milliman MedInsight Emerging Experience Research Database, encompassing 8.1 million patients nationwide, to evaluate the spending and utilization of these medications during the pandemic.
Some key findings from the research include:
Despite the significant findings, the study does come with limitations. The cohort used a convenience sample, meaning that the data was drawn from a readily available group rather than a randomly selected population. While this could impact the generalizability of the findings, previous studies have confirmed that the demographics of the dataset reflect the overall U.S. population. Moreover, the study did not account for medications obtained without prescriptions or insurance, which may have led to variations in price and spending estimates.
This research represents the first comprehensive analysis of trends in the utilization and spending of ivermectin and hydroxychloroquine in U.S. outpatient settings throughout the COVID-19 pandemic. The findings point to potential wasteful spending and highlight the risks associated with non-evidence-based care during a public health crisis. The authors suggest that multi-level strategies are necessary to promote equitable, high-quality healthcare while minimizing reliance on ineffective treatments.
Section: Politics
Section: News
Section: News
Section: Health
Section: News
Section: News
Section: Travel
Section: News
Section: News
Section: Politics
Health Insurance in Germany is compulsory and sometimes complicated, not to mention expensive. As an expat, you are required to navigate this landscape within weeks of arriving, so check our FAQ on PKV. For our guide on resources and access to agents who can give you a competitive quote, try our PKV Cost comparison tool.
Germany is famous for its medical expertise and extensive number of hospitals and clinics. See this comprehensive directory of hospitals and clinics across the country, complete with links to their websites, addresses, contact info, and specializations/services.
Join us for an exciting theatrical experience on Saturday, May 10, 2025, from 19:30 to 22:00 at the Münchner Kammerspiele - Werkraum. This performance, directed by Melina Dressler, is a directorial exercise inspired by Heiner Müller's 'Quartett' and incorporates texts by Michel Foucault. The...
No comments yet. Be the first to comment!